Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five year follow-up
- 26 February 2009
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 256 (2), 225-233
- https://doi.org/10.1007/s00415-009-0076-2
Abstract
To assess the long-term efficacy and safety of bilateral subthalamic nucleus (STN) stimulation in patients with advanced Parkinson's disease (PD). 42 consecutive patients with idiopathic PD treated with bilateral STN stimulation were enrolled. Parkinsonian status, medication intake and neuropsychological evaluation were assessed preoperatively and at 1 and 5 years postoperatively in on and off medication/on and off stimulation conditions. 23 patients could be followed-up 5 years after surgery. In the remaining cases, 5 died, 1 could not be assessed because of device removal for infection, 1 decided not to be stimulated, and 11 were lost of follow-up (one because of a liver carcinoma and the others because they refused the formal four conditions of assessment). STN stimulation reduced the UPDRS motor score by 55 % compared to baseline in the off-medication conditions. Tremor, rigidity, bradykinesia, postural stability, and gait improved by 74 %, 66 %, 59 %, 17 % and 37 %, respectively. UPDRS part II scores were reduced by 38 %. The dopaminergic treatment daily dose was reduced by 54.4 % after surgery. Axial dopa-unresponsive signs worsened in some patients. Among the 42 initial patients we observed the following: 2 brain hemorrhages, 3 infections of the device, 2 phlebitis and 1 pulmonary embolism. In addition, 2 patients needed a repositioning of the electrode. Among the 23 patients followed at 5 years, long lasting side effects consisted in dysarthria (56 %), depression (39 %), eyelid opening apraxia (30.4 %) and apathy (4.3 %). Our data confirm that bilateral STN stimulation is beneficial in the long-term for PD patients but does not prevent disease progression and the occurence of axial levodopa unresponsive signs in some patients.Keywords
This publication has 52 references indexed in Scilit:
- Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?Neurology, 2007
- Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow upJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-upBrain, 2005
- Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow upJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?Journal of Neurology, Neurosurgery & Psychiatry, 2005
- Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow upJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Hemorrhagic complication of stereotactic surgery in patients with movement disordersJournal of Neurosurgery, 2003
- Behavioural disorders, Parkinson's disease and subthalamic stimulationJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson's disease: one year follow-upJournal of Neural Transmission, 1999